![Dov Goldstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dov Goldstein
Direttore Finanziario/CFO presso
BIOAGE LABS, INC.
Patrimonio netto: 393 063 $ in data 31/08/2026
Profilo
Dr. Dov A. Goldstein is a Chief Financial Officer at BioAge Labs, Inc., an Independent Director at Coya Therapeutics, Inc. and an Independent Director at Gain Therapeutics, Inc. He is on the Board of Directors at Coya Therapeutics, Inc., Gain Therapeutics, Inc. and ADMA Plasma Biologics, Inc. Dr. Goldstein was previously employed as a Chief Financial & Business Officer by Indapta Therapeutics, Inc., a Chairman by NeuBase Therapeutics, Inc., a President, CEO, Treasurer & Director by RIGImmune, Inc., a Chief Financial Officer by Schrödinger, Inc., a Chief Financial Officer by Loxo Oncology, Inc., an Independent Director by Esperion Therapeutics, Inc., an Independent Director by Cempra, Inc., an Independent Non-Executive Director by ADMA Biologics, Inc., a Chief Executive Officer & Director by MIA Dynamics Motors Ltd., an Operating Partner by Aisling Capital LLC, a Managing Partner by RCMC Capital LLP, a Chief Financial Officer by Vicuron Pharmaceuticals Inc, and a Director-Venture Analysis by HealthCare Ventures LLC.
He also served on the board at Neubase Therapeutics, Inc. /Old/, Cempra Pharmaceuticals, Inc., Durata Therapeutics, Inc., Global Pay (P.C.S) Ltd., Geom Therapeutics, Inc., Scerene Healthcare, Inc. and Topaz Pharmaceuticals, Inc. He received his undergraduate degree from Stanford University, an MBA from Columbia Business School and a doctorate degree from Yale School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
BIOAGE LABS, INC. 0,08% | 23/04/2026 | 36.575 ( 0,08% ) | 347 463 $ | 31/08/2026 |
| 01/05/2026 | 10.000 ( 0,04% ) | 45 600 $ | 31/08/2026 | |
| 15/07/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Posizioni attive di Dov Goldstein
| Società | Posizione | Inizio |
|---|---|---|
| GAIN THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/01/2021 |
| COYA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/03/2021 |
| BIOAGE LABS, INC. | Direttore Finanziario/CFO | 01/11/2021 |
ADMA Plasma Biologics, Inc.
 ADMA Plasma Biologics, Inc. BiotechnologyHealth Technology Develops medicines for treatment of infectious diseases | Direttore/Membro del Consiglio | 04/11/2009 |
Precedenti posizioni note di Dov Goldstein
| Società | Posizione | Fine |
|---|---|---|
| NEUBASE THERAPEUTICS, INC. | Presidente | 04/01/2025 |
Indapta Therapeutics, Inc.
 Indapta Therapeutics, Inc. BiotechnologyHealth Technology Develops proprietary, off-the-shelf, allogeneic natural killer cell therapy to treat cancer | Direttore Finanziario/CFO | 01/11/2021 |
| ADMA BIOLOGICS, INC. | Direttore/Membro del Consiglio | 18/06/2020 |
RIGImmune, Inc.
 RIGImmune, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biopharmaceutical research company that develops RNA immunotherapies | Amministratore Delegato | 01/01/2020 |
| ESPERION THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/05/2019 |
Formazione di Dov Goldstein
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
64
Relazioni di 1° grado
27
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 27 |
|---|---|
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Aisling Capital LLC
 Aisling Capital LLC Investment ManagersFinance Aisling Capital invests in both private and public companies located in the Unites States. The firm targets companies operating in the fields of developing & commercializing important and innovative healthcare products, services & technologies sectors and industries. It provides financing for royalty deals, large cap leveraged buyout, seed, early and late stage capital requirements in the form of equity and debt. | Finance |
Cempra Pharmaceuticals, Inc.
 Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops medicines for treating drug-resistant bacterial infections | Health Technology |
Topaz Pharmaceuticals, Inc.
 Topaz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which focuses on developing and commercializing treatments for the pediatric and dermatology markets | Health Technology |
ADMA Biologics, Inc.
 ADMA Biologics, Inc. BiotechnologyHealth Technology Develops, manufactures and markets specialty biologics | Health Technology |
MIA Dynamics Motors Ltd.
 MIA Dynamics Motors Ltd. Trucks/Construction/Farm MachineryProducer Manufacturing Develops off-road all-terrain vehicles and wheel platforms | Producer Manufacturing |
Cempra, Inc.
 Cempra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in manufacturing pharmaceutical products | Health Technology |
HealthCare Ventures LLC
 HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures invests in companies located in the United States. The firm target companies operating in the fields of life sciences, pharmaceuticals and biotechnology. It provides financing for early and later stage capital requirements. | Finance |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galileo Tech Ltd.
 Galileo Tech Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the operation of waste recycling plant and in the financial technology sectors | Commercial Services |
Schrödinger, Inc.
 Schrödinger, Inc. Packaged SoftwareTechnology Services Develops physics-based software platform which enables discovery of novel molecules for drug development and materials applications | Technology Services |
ADMA Plasma Biologics, Inc.
ADMA Plasma Biologics, Inc. BiotechnologyHealth Technology Develops medicines for treatment of infectious diseases | Health Technology |
Scerene Healthcare, Inc.
 Scerene Healthcare, Inc. Medical/Nursing ServicesHealth Services Develops and delivers personal care solutions | Health Services |
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics for infectious diseases and acute illnesses | Health Technology |
RCMC Capital LLP
 RCMC Capital LLP Financial ConglomeratesFinance Provides investment services | Finance |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicine for cancer treatment | Health Technology |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioAge Labs, Inc.
 BioAge Labs, Inc. BiotechnologyHealth Technology Develops therapies obesity for metabolic diseases | Health Technology |
Geom Therapeutics, Inc.
 Geom Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of antibiotic for MDR gram negative infections | Commercial Services |
Neubase Therapeutics, Inc. /Old/
 Neubase Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops peptide-nucleic acid antisense oligonucleotide platform | Health Technology |
NeuBase Therapeutics, Inc.
 NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders | Health Technology |
Indapta Therapeutics, Inc.
Indapta Therapeutics, Inc. BiotechnologyHealth Technology Develops proprietary, off-the-shelf, allogeneic natural killer cell therapy to treat cancer | Health Technology |
Gain Therapeutics, Inc.
 Gain Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Coya Therapeutics, Inc.
 Coya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on research and development of therapies to enhance the function of regulatory T cells | Health Technology |
RIGImmune, Inc.
RIGImmune, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biopharmaceutical research company that develops RNA immunotherapies | Commercial Services |
